MACROGENICS INC 8-K

What Happened

• MacroGenics, Inc. (MGNX) filed a Form 8-K on March 9, 2026 (Item 2.02) announcing its financial and operating results for the year ended December 31, 2025.
• The company attached a press release dated March 9, 2026 as Exhibit 99.1 to the 8-K with the full announcement. The 8-K was signed by Jeffrey Peters, Senior Vice President, General Counsel and Corporate Secretary.
• The filing states that the information in the 8-K (including Exhibit 99.1) is furnished, not “filed,” and therefore is not subject to Section 18 liability or automatically incorporated by reference into other SEC filings unless a later filing expressly does so.

Key Details

• Filing date: March 9, 2026 (Form 8-K, Item 2.02).
• Period covered: Results reported are "as of and for the year ended December 31, 2025."
• Exhibit: Press release dated March 9, 2026 attached as Exhibit 99.1.
• Signature: Report signed by Jeffrey Peters, SVP, General Counsel & Corporate Secretary.

Why It Matters

• This 8-K notifies investors that MacroGenics has released its full-year 2025 financial and operating results; those results can affect valuation, guidance expectations, and sentiment.
• Investors should read the attached press release (Exhibit 99.1) for the specific earnings, revenue, expense, cash position, and any operational or pipeline updates, and watch for the company’s Form 10-K or earnings presentation for more detailed financial statements and management discussion.